Search

everythinglearnresearchcommunity

for

Search:↓

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

The dietary supplement helped increase hair growth in women with hair loss.

Researchers established normal hair and scalp characteristics for healthy women using trichoscopy.

A systematic approach is crucial for managing hair loss in women.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Hair proteins have weak spots in their α-helical segments.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Consider benefits and risks of new alopecia treatments for safety.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

The hydrogel with silver and mangiferin helps heal wounds by killing bacteria and aiding skin and tissue repair.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.